Respectfully, that's exactly what this Liberal government has done since the beginning of our term of government, take on this challenge of trying to work with the pharmaceutical companies, the patient groups and, indeed, the provinces and territories to look at how we reduce costs of medication for Canadians in this country.
This is an important piece. I absolutely agree with the member that COVID-19 has made this more challenging, given the landscape of COVID-19 and the contribution that pharmaceutical companies are making to beating back COVID-19.
We'll continue. We haven't stopped talking to all of the stakeholders that the member opposite has referred to. We'll continue that hard work so that we can determine the future of the industry here in Canada and also how we move forward with both of those goals: to make sure that Canadians have the access to the best and most cutting-edge drugs in the world, and to make sure that Canadians can afford those drugs. Both of those principles are important.